[Fetal hepatocellular suspension transfusion in the treatment of chronic active hepatitis B].
Using the paired method and the same observation standard, 35 pairs of patients (70 patients) suffering from chronic active hepatitis B were treated with FHST or glucose in 5 hospitals. After three months of treatment a significant decrease in ALT, TTT and a significant increase in PTA were observed in FHST group as compared with the control group (p less than 0.05-0.01). There was no significant change in HBVM in both groups. No side effect was observed during the period of treatment.
Zhu
R P
RP
Beijing Yiuan Hospital.
Lin
X Y
XY
Wang
J T
JT
D000328:Adult; D005260:Female; D016332:Fetal Tissue Transplantation; D006509:Hepatitis B / Q000601:surgery*; D006521:Hepatitis, Chronic / Q000601:surgery*; D006801:Humans; D008099:Liver / Q000196:embryology; D008111:Liver Function Tests; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged